Related Experiment Video

Updated: Jun 7, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

221

Comment on "Tumor deposits should not be placed in the M category of TNM: A comparative survival analysis using SEER

Chong-Jie Zhang1

  • 1Department of Colorectal Surgery, Ningbo No. 2 Hospital, Ningbo, China.

International Journal of Cancer
|November 11, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Non-Destructive Evaluation of Regional Cell Density Within Tumor Aggregates Following Drug Treatment
10:13

Non-Destructive Evaluation of Regional Cell Density Within Tumor Aggregates Following Drug Treatment

Published on: June 21, 2022

2.1K
Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment
05:17

Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment

Published on: May 14, 2019

8.6K

Related Experiment Videos

Last Updated: Jun 7, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

221
Non-Destructive Evaluation of Regional Cell Density Within Tumor Aggregates Following Drug Treatment
10:13

Non-Destructive Evaluation of Regional Cell Density Within Tumor Aggregates Following Drug Treatment

Published on: June 21, 2022

2.1K
Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment
05:17

Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment

Published on: May 14, 2019

8.6K

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328

Articles linked to this work by shared authors, journal, and citation graph.

Spatial Transcriptomic Profiling Reveals a Fibroblast-Associated Extracellular Matrix Niche in KRAS G12C-Mutant Lung Adenocarcinoma Primary Tumors From Patients With Metastasis.

International journal of cancer·2026

BRCA1/2 Carriers With Breast-Ovarian Double Primary Cancers Versus Ovarian Cancer Alone: Mutation Profiles and Survival Outcomes.

International journal of cancer·2026

Human Protein Biomarkers Outperform Bacterial Proteins in Colorectal Cancer Detection.

International journal of cancer·2026

Short-Term PM2.5 Exposure and Daily Cancer Mortality Across 47 Japanese Prefectures: A Nationwide Time-Stratified Case-Crossover Study, 2013-2022.

International journal of cancer·2026

Prospective Phase II Study of Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma (NEOFOL).

International journal of cancer·2026

Epigenetic Predictors of Smoking: External Validation and Association With Smoking-Related Cancer Risk.

International journal of cancer·2026

Epidemiology and Management of Neuroendocrine Neoplasms of Unknown Primary in Switzerland.

Endocrine connections·2026

Laparoscopic hemicolectomy with intracorporeal anastomosis for ascending colon cancer in situs inversus totalis: a case report and literature review.

Frontiers in oncology·2026

Contribution of Unspecified Brain Malignancies to Overall Brain Cancer Mortality Trends in the United States: A 26 years CDC WONDER Analysis.

JPMA. The Journal of the Pakistan Medical Association·2026

Comparative effectiveness and safety of upadacitinib versus vedolizumab in anti-TNF-exposed patients with ulcerative colitis.

Inflammatory bowel diseases·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

[Special tumor entities : New results at the 2026 ASCO Annual Meeting].

HNO·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us